There are currently 299 active clinical trials seeking participants for Cancer research studies. The states with the highest number of trials for Autism participants are California, Texas, New York and Florida.
Connect for Cancer Prevention Study (Connect)
NCT04609072
Recruiting
Background: The National Cancer Institute, part of the National Institutes of Health, has partnered with nine health care systems across the U.S. to establish the Connect for Cancer Prevention Study. While researchers have made important discoveries, there is more to learn to lower the number of people affected by cancer. By taking part in Connect, participants can help researchers learn how the way we live, our genetics, and our health history may affect cancer risk. Objective: To study and... Read More
Gender:
All
Ages:
Between 30 years and 70 years
Trial Updated:
04/25/2024
Locations: Kaiser Permanente Colorado, Denver, Colorado +8 locations
Conditions: Cancer, General Research Use
Register for Updates
UNC Metastatic Cancer Radiation Therapy Registry
NCT06306924
Recruiting
The purpose of this registry is to collect clinical data from participants attending UNC Hospitals who present with metastatic cancer and are evaluated to receive radiation therapy as part of their standard of care treatment. The goal of this study is to provide a foundation for studies designed to identify projects across the translational continuum related to metastatic cancer and radiation therapy treatment. The relevant clinical data will be linked to patient-reported outcomes (PROs) thus al... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
04/25/2024
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill, North Carolina
Conditions: Cancer, Metastatic Cancer
Register for Updates
Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers
NCT05436327
Recruiting
To improve patient-centered outcomes for older patients with cancer considering or receiving chemotherapy and their caregivers. To do this, the project team will (a) establish the effectiveness of GA on communication about age-related concerns, patient and caregiver satisfaction with communication about age-related concerns, quality of life, and patient-reported side effects of chemotherapy; (b) evaluate the success of the implementation strategies on the adoption, reach, and fidelity of impleme... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
04/24/2024
Locations: MD Anderson Cancer Center, Houston, Texas
Conditions: Cancer, Aging, Communication
Register for Updates
RISE (Reinvent, Integrate, Strengthen, Expand) Self-Management Program for Cancer Survivors: A Feasibility Study
NCT05128838
Recruiting
This is a prospective feasibility study using a convenience sample of cancer survivors from Cedars-Sinai and its surrounding catchment area. As this study will be primarily focused on optimization of the RISE (Re-invent, Integrate, Strengthen, Expand) protocol, there will be no control group or randomization of participants. The RISE intervention is informed by the principles of Lifestyle Redesign, an occupational therapy-based therapeutic technique focused on measurable, individually-tailored,... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
04/23/2024
Locations: Cedars-Sinai Medical Center, Los Angeles, California
Conditions: Cancer, Survivorship
Register for Updates
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer
NCT05997017
Recruiting
A Phase 2 Multi-center Open-label Trial of nab-Sirolimus in Combination with Letrozole in Advanced or Recurrent Endometrioid Endometrial Cancer
Gender:
All
Ages:
18 years and above
Trial Updated:
04/23/2024
Locations: Mount Sinai Comprehensive Cancer Center, Miami Beach, Florida +7 locations
Conditions: Endometrial Cancer, Endometrioid Tumor, Cancer, Tumor, Recurrent Endometrial Carcinoma, Endometrioid Endometrial Cancer
Register for Updates
Augmented Whole-body Scanning Via Magnifying PET/CT (AWSM-PET/CT) Techniques Abilities to Improve Upon the Diagnostic Accuracy of the Standard-of-care (SOC) FDG PET/CT for Malignant Lesion Detection
NCT05513027
Recruiting
Fluorodeoxyglucose (FDG)-positron emission tomography (PET)/computed tomography (CT) has been demonstrated to outperform other imaging modalities such as CT and magnetic resonance imaging (MRI) for the detection of metastatic cancers. Therefore, it is currently used for cancer staging, re-staging, and for monitoring response to therapy for many types of cancers. Despite its wide use and success, the diagnostic accuracy of FDG-PET/CT is suboptimal for lesions that are significantly smaller than 1... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
04/22/2024
Locations: Washington University School of Medicine, Saint Louis, Missouri
Conditions: Cancer
Register for Updates
Tobacco Cessation Care for Cancer Patients by Automated Interactive Outreach
NCT05829824
Recruiting
This is a multi-arm, randomized controlled, pilot study which will recruit cancer patients who have been seen by a UCSF Cancer Center-affiliated clinical department to evaluate the efficacy of "CareConnect". This is the first study to assess the efficacy CareConnect, a combination of the Ask-Advise-Connect (AAC) with an Interactive Voice Response (IVR) delivering cancer-targeted educational messages to support referral to smoking cessation resources for patients with cancer.
Gender:
All
Ages:
18 years and above
Trial Updated:
04/22/2024
Locations: University of California, San Francisco, San Francisco, California
Conditions: Cancer, Tobacco Dependence, Tobacco Use Cessation
Register for Updates
Education Tools to Support Pediatric Survivor Care
NCT04257058
Recruiting
This study aims to evaluate the impact of electronic educational materials on adolescent and young adult ("AYA") survivors' knowledge about late effects, perceived benefits, self-efficacy, and intentions to engage in lifelong survivor care.
Gender:
All
Ages:
Between 18 years and 25 years
Trial Updated:
04/22/2024
Locations: Children's Healthcare of Atlanta, Atlanta, Georgia
Conditions: Cancer, Pediatric Cancer
Register for Updates
A Phase 2 Study of CRG-022 in Patients With Relapsed/Refractory Large B-cell Lymphoma
NCT05972720
Recruiting
This is a prospective, open-label, multi-center clinical study designed to evaluate the safety, tolerability, efficacy, pharmacokinetics, pharmacodynamics, and immunogenicity of CRG-022, a CD22-directed autologous Chimeric Antigen Receptor (CAR) T-cell therapy for the treatment of relapsed or refractory large B-cell lymphoma (LBCL).
Gender:
All
Ages:
18 years and above
Trial Updated:
04/19/2024
Locations: University of Arkansas Medical Sciences, Little Rock, Arkansas +22 locations
Conditions: Cancer, Relapsed/Refractory Large B-cell Lymphoma (LBCL)
Register for Updates
Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC
NCT05510908
Recruiting
This study is being done to understand how many people with HIV (PWH) present for cancer care across the AIDS Malignancy Consortium in the United States and if there are reasons that some PWH choose to participate, or not in cancer clinical trials. Optional quality of life surveys will be used to learn more about how HIV and cancer and HIV and cancer treatment affect people.
Gender:
All
Ages:
18 years and above
Trial Updated:
04/18/2024
Locations: Moores UCSD Cancer Center, La Jolla, California +10 locations
Conditions: HIV-Associated Malignant Neoplasm, HIV Infections, Cancer, AIDS Related Lymphoma, AIDS-related Kaposi Sarcoma, AIDS-Related Malignancy, Anal Cancer, HPV-Related Malignancy
Register for Updates
Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer
NCT05474846
Recruiting
To learn if Cognitive Behavior Therapy (called CBT), combined with either Bright Light Therapy (called BLT), methylphenidate, and/or melatonin, can help improve sleep and other related symptoms such as fatigue, anxiety, and depression in cancer patients. This is an investigational study. In this study, BLT, Methylphenidate and Melatonin will be compared to their placebos.
Gender:
All
Ages:
18 years and above
Trial Updated:
04/18/2024
Locations: MD Anderson Cancer Center, Houston, Texas
Conditions: Sleep, Fatigue, Anxiety, Cancer, Depression
Register for Updates
Long-Term Follow-Up Safety Study of Subjects Treated With SynKIR-110 in Cancer Studies
NCT06377202
Recruiting
The primary objective of this study is to evaluate the long-term safety of SynKIR- 110 administered to adult subjects with solid tumors expressing mesothelin.
Gender:
All
Ages:
18 years and above
Trial Updated:
04/17/2024
Locations: University of Pennsylvania, Philadelphia, Pennsylvania
Conditions: Cancer
Register for Updates